MRK Merck & Company Inc.
- 15.471 P/E
- 4.024 P/S
- 3.492 P/B
- 3.849 EPS
- 12.10% Cash ROIC
- 0.84 Cash Ratio
- 1.8 / 3% Dividend
- 11.40M Avg. Vol.
- 2.83B Shares
- 168.23B Market Cap.
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, ...
StreetWise Report - 11 hours ago
Merck & Co. (MRK) - Analysts' Recent Ratings Updates - Mideast Time
Equities.com - May 26, 2015
StreetWise Report - May 26, 2015
OctaFinance.com - May 11, 2015
Merck & Co. Given Consensus Recommendation of "Hold" by Brokerages ... - sleekmoney
International Business Times - Apr 28, 2015
Pfizer, Merck and Bristol-Myers Squibb Report Solid Results - Wall Street Journal
StreetWise Report - 13 hours ago
Markets Wired - May 8, 2015
Large Cap Stocks to Keep Your Eyes on- Merck (MRK), Bank of America (BAC ... - Techsonian (press release)
Bidness ETC - Apr 28, 2015
OctaFinance.com - Apr 29, 2015
Merck & Co. Inc. (MRK) Is Up Sharply After Q1 Profit Surpassed Expectations - Nasdaq
Equities.com - May 22, 2015